Trial intelligence / Profile preview

Varenicline for Alcohol Dependence

NCT00705523Phase 2Completed

Sponsor
University of Pennsylvania
Start
Jun 2008
Primary completion
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in alcohol dependence comparing Varenicline with Placebo (2 arms). Primary endpoint: Rate of Heavy Drinking Days Per Week. Started Jun 2008; status: completed.

02

Drugs

varenicline
03

Conditions

alcohol dependence

Beyond the preview

Go deeper on NCT00705523.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00705523.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call